Cargando…

Intensity Modulated Radiation Therapy for Syringomatous Carcinoma of the Face: A Case Report

Detalles Bibliográficos
Autores principales:	Sasamura, Kazuma, Matsubara, Daigoro, Kojima, Mio, Yuasa-Nakagawa, Keiko, Toda, Kazuma, Miura, Keiko, Yoshimura, Ryoichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Cutaneous Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639763/ https://www.ncbi.nlm.nih.gov/pubmed/31360802 http://dx.doi.org/10.1016/j.adro.2019.03.013

Ejemplares similares

Hyperthermia and Hyper-fractionated Radiation for a Cutaneous Squamous Cell Carcinoma Progressing on Standard Therapy: A Case Report
por: DeCesaris, Cristina, et al.
Publicado: (2018)

Low-cost optical scanner and 3-dimensional printing technology to create lead shielding for radiation therapy of facial skin cancer: First clinical case series
por: Sharma, Ankur, et al.
Publicado: (2018)

High-resolution, ultrasound-guided, high-dose-rate, surface brachytherapy for basal cell carcinoma of the skin: A case report
por: Zhu, Simeng, et al.
Publicado: (2018)

Outcomes of radiotherapy in advanced external auditory canal cancer
por: Nagano, Takuya, et al.
Publicado: (2019)

Comparison Between Dose-Escalated Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy for Salvage Radiation Therapy After Prostatectomy
por: Shimoyachi, Nana, et al.
Publicado: (2021)

Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study
por: Sasamura, Kazuma, et al.
Publicado: (2020)

Pleomorphic Lipoma of the Tongue as Potential Mimic of Liposarcoma
por: D’Antonio, Antonio, et al.
Publicado: (2013)

Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature
por: Shalbaf, Mohammad, et al.
Publicado: (2019)

Robust measurement of clinical improvement in patients with cutaneous lupus erythematosus
por: Nanes, Benjamin A, et al.
Publicado: (2020)

Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program
por: Izmirly, Peter, et al.
Publicado: (2019)

Cutaneous lupus concerns from the patient perspective: a qualitative study
por: Yan, Daisy, et al.
Publicado: (2021)

Development of a working core outcome set for cutaneous lupus erythematosus: a practical approach to an urgent unmet need
por: Guo, Lisa N, et al.
Publicado: (2021)

Depression, stigma and social isolation: the psychosocial trifecta of primary chronic cutaneous lupus erythematosus, a cross-sectional and path analysis
por: Drenkard, Cristina, et al.
Publicado: (2022)

Panoramic view of clinical features of lupus erythematosus: a cross-sectional multicentre study from China
por: Jin, Hui, et al.
Publicado: (2023)

State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus
por: Zhao, Megan, et al.
Publicado: (2023)

Genotype-guided new approach for dose optimisation of hydroxychloroquine administration in Chinese patients with SLE
por: Xie, Han, et al.
Publicado: (2023)

Syringomatous Tumor of the Nipple
por: Favre, Nicole M., et al.
Publicado: (2022)

A Case of Syringomatous Adenoma of the Nipple
por: Ichinokawa, Yuko, et al.
Publicado: (2012)

Syringomatous adenoma of nipple--a case report.
por: Hwang, T. S., et al.
Publicado: (1987)

Syringomatous adenoma of the nipple: a case report
por: Ishikawa, Shoichi, et al.
Publicado: (2015)

Syringomatous dermatitis: a myth or an existing entity?
por: Hassab-El-Naby, Hussein M. M., et al.
Publicado: (2023)

Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
por: Lacouture, Mario E., et al.
Publicado: (2016)

Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
por: Spillane, Susan, et al.
Publicado: (2020)

Comprehensive Clinical Trial Data Summation for BRAF‐MEK Inhibition and Checkpoint Immunotherapy in Metastatic Melanoma
por: Luke, Jason J.
Publicado: (2019)

Real‐World Clinical Outcomes in Patients with Locally Advanced or Metastatic Merkel Cell Carcinoma Treated in U.S. Oncology Clinical Practices: Results from SPEAR‐Merkel
por: Bhanegaonkar, Abhijeet, et al.
Publicado: (2021)

Multidisciplinary Care of BRAF‐Mutant Stage III Melanoma: A Physicians Perspective Review
por: Cornelius, Lynn A., et al.
Publicado: (2021)

Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma
por: Di Guardo, Lorenza, et al.
Publicado: (2021)

Vismodegib for Preservation of Visual Function in Patients with Advanced Periocular Basal Cell Carcinoma: The VISORB Trial
por: Kahana, Alon, et al.
Publicado: (2021)

Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta‐analysis of individualized participant data
por: Ørholt, Mathias, et al.
Publicado: (2022)

Synovial sarcomas: A single surgeon experience of 130 cases
por: Andreani, Lorenzo, et al.
Publicado: (2022)

Intralesional margin after excision of a high‐grade osteosarcoma: Is it a catastrophe?
por: Tsagkozis, Panagiotis, et al.
Publicado: (2022)

Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy
por: Anstadt, Emily J, et al.
Publicado: (2022)

Management of Acral and Mucosal Melanoma: Medical Oncology Perspective
por: Jung, Seungyeon, et al.
Publicado: (2022)

A prospective real‐world study of the diffuse‐type tenosynovial giant cell tumor patient journey: A 2‐year observational analysis
por: Bernthal, Nicholas M., et al.
Publicado: (2022)

Subcostal lymph nodes: An unusual sentinel lymph node basin in cutaneous melanoma
por: Marsh, Katherine M., et al.
Publicado: (2022)

Health Care Utilization and Costs in Systemic Therapies for Metastatic Melanoma from 2016 to 2020
por: Qian, Mollie F, et al.
Publicado: (2022)

Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant Immunotherapy
por: Atkinson, Thomas M, et al.
Publicado: (2023)

Prognostic Risk Stratification and End-of-Life Care Outcomes in Patients With Metastatic Melanoma Treated With Immune Checkpoint Inhibitors
por: Grad, Robert N, et al.
Publicado: (2023)

Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
por: Stukalin, Igor, et al.
Publicado: (2023)

Retreatment of Patients With Metastatic Cutaneous Melanoma Who Relapse After Elective Checkpoint Inhibitor Discontinuation After a Complete Remission
por: Sadrolashrafi, Kaviyon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_174ffm1t1e250kbadmojp8cdfp